These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9857932)

  • 1. Standardization activities of markers of cardiac damage: the need of a comprehensive approach.
    Panteghini M
    Eur Heart J; 1998 Nov; 19 Suppl N():N8-11. PubMed ID: 9857932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays.
    Dati F; Panteghini M; Apple FS; Christenson RH; Mair J; Wu AH
    Scand J Clin Lab Invest Suppl; 1999; 230():113-23. PubMed ID: 10389209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFCC Committee on Standardization of Markers of Cardiac Damage: premises and project presentation. International Federation of Clinical Chemistry and Laboratory Medicine.
    Panteghini M
    Clin Chem Lab Med; 1998 Nov; 36(11):887-93. PubMed ID: 9877096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview and ranking of biochemical markers of cardiac disease. Strengths and limitations.
    Henderson AR
    Clin Lab Med; 1997 Dec; 17(4):625-54. PubMed ID: 9439876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troponin T or troponin I or CK-MB (or none?).
    Collinson PO
    Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes.
    Panteghini M; Apple FS; Christenson RH; Dati F; Mair J; Wu AH
    Scand J Clin Lab Invest Suppl; 1999; 230():103-12. PubMed ID: 10389208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of cardiac markers.
    Apple FS
    Scand J Clin Lab Invest Suppl; 2005; 240():107-11. PubMed ID: 16112967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes.
    Apple FS; Jesse RL; Newby LK; Wu AH; Christenson RH; ;
    Circulation; 2007 Apr; 115(13):e352-5. PubMed ID: 17384332
    [No Abstract]   [Full Text] [Related]  

  • 9. IFCC Committee on Standardization of Markers of Cardiac Damage: Premises and Project Presentation.
    EJIFCC; 1999 Jul; 11(2):45-48. PubMed ID: 30720255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry.
    Panteghini M; Apple FS; Christenson RH; Dati F; Mair J; Wu AH
    Clin Chem Lab Med; 1999 Jun; 37(6):687-93. PubMed ID: 10475079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers of thrombolytic success. IFCC Committee on Standardization of Markers of Cardiac Damage.
    Apple FS
    Scand J Clin Lab Invest Suppl; 1999; 230():60-6. PubMed ID: 10389203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods.
    Hallermayer K; Klenner D; Vogel R
    Scand J Clin Lab Invest Suppl; 1999; 230():128-31. PubMed ID: 10389211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Troponins and other biochemical cardiac markers--time for a change].
    Strømme JH; Rolstad OJ; Mangschau A
    Tidsskr Nor Laegeforen; 2000 Jun; 120(16):1863-9. PubMed ID: 10925614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FRISC experience with troponin T. Use as decision tool and comparison with other prognostic markers.
    Lindahl B; Venge P; Wallentin L
    Eur Heart J; 1998 Nov; 19 Suppl N():N51-8. PubMed ID: 9857941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. IFCC Subcommittee on Standardization of Cardiac Markers (S-SCM).
    Wu AH
    Scand J Clin Lab Invest Suppl; 1999; 230():74-82. PubMed ID: 10389205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum concentrations of markers of myocardial injury following treadmill exercise testing in patients with suspected ischaemic heart disease.
    Ashmaig ME; Starkey BJ; Ziada AM; Amro AA; Sobki SH; Ferns GA
    Med Sci Monit; 2001; 7(1):54-7. PubMed ID: 11208493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imprecision of cardiac marker analyses among laboratories on the basis of external quality assurance results: Finnish experience.
    Penttilä IM; Laatikainen A; Penttilä K; Punnonen K; Rantanen T; Savolainen K; Tiikkainen U
    Scand J Clin Lab Invest; 2007; 67(5):507-18. PubMed ID: 17763187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic strategies in myocardial infarction using myoglobin measurement.
    Plebani M; Zaninotto M
    Eur Heart J; 1998 Nov; 19 Suppl N():N12-5. PubMed ID: 9857933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troponins in acute coronary syndromes.
    Scirica BM; Morrow DA
    Semin Vasc Med; 2003 Nov; 3(4):363-74. PubMed ID: 15199443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality specifications for biochemical markers of myocardial injury.
    Zaninotto M; Mion M; Altinier S; Forni M; Plebani M
    Clin Chim Acta; 2004 Aug; 346(1):65-72. PubMed ID: 15234637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.